Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia Boglarka Gyurkocza, Jonathan Gutman, Eneida R. Nemecek, Merav Bar, Filippo Milano, Aravind Ramakrishnan, Bart Scott, Min Fang, Brent Wood, John M. Pagel, Joachim Baumgart, Colleen Delaney, Richard T. Maziarz, Brenda M. Sandmaier, Elihu H. Estey, Frederick R. Appelbaum, Barry E. Storer, Hans Joachim Deeg Biology of Blood and Marrow Transplantation Volume 20, Issue 4, Pages 549-555 (April 2014) DOI: 10.1016/j.bbmt.2014.01.009 Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Cumulative incidence of GVHD: (A) acute, grades II-IV and III-IV, and (B) chronic, extensive. Biology of Blood and Marrow Transplantation 2014 20, 549-555DOI: (10.1016/j.bbmt.2014.01.009) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 OS, relapse mortality, and NRM (N = 96). Biology of Blood and Marrow Transplantation 2014 20, 549-555DOI: (10.1016/j.bbmt.2014.01.009) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 Cytogenetics and outcome for (A and B) all patients, (C and D) patients with MDS (n = 36), and (E and F) patients with AML (n = 60). Biology of Blood and Marrow Transplantation 2014 20, 549-555DOI: (10.1016/j.bbmt.2014.01.009) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 4 Pretransplant MRD and relapse (A) and survival (B) in patients with AML in morphologic remission (n = 56). Biology of Blood and Marrow Transplantation 2014 20, 549-555DOI: (10.1016/j.bbmt.2014.01.009) Copyright © 2014 American Society for Blood and Marrow Transplantation Terms and Conditions